Diseases - Strategic Insights Report (Page 35)

Diseases

Pulmonary Complications in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: A Major Cause of Morbidity

Researchers at the First Affiliated Hospital of Shandong First Medical University published a new study on the pulmonary complications that arise after pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT). The study found that pulmonary complications are a significant cause of morbidity in children undergoing allo-HSCT, particularly those with malignant diseases.

Diseases

Hybrid Deep Learning Framework for Maize Leaf Disease Detection

Research investigators at Gachon University in South Korea have published a new study that focuses on developing a robust hybrid deep learning framework for enhanced maize leaf disease classification. This study aims to overcome the limitations of traditional classification techniques by introducing a powerful combination of convolutional neural networks (CNNs)

Diseases

Transforming CNS Clinical Trials with Digital Biomarkers and At-Home Innovations

Thought-leaders from the industry and academia gathered to discuss the revolutionary impact of at-home and in-clinic innovations in central nervous system (CNS) clinical trials. The panel highlighted the transformative potential of digital biomarkers, which can enable personalized treatment, leaner trial designs, and accelerated clinical development of CNS therapies. The discussion

Diseases

Lyme Disease Pipeline 2025: In-depth Analysis and Emerging Therapies Report

The Lyme disease pipeline is abuzz with activity as numerous companies work tirelessly to develop effective treatment therapies. According to a recent report by DelveInsight, the Lyme disease pipeline consists of 7+ key companies, with 7+ Lyme disease treatment therapies in various stages of clinical development. The report provides an

Diseases

Young COPD: A Growing Concern for Mortality Risk and Respiratory Health

A new study published in the Journal of the American Medical Association (JAMA) has highlighted the alarming prevalence of "young COPD" (chronic obstructive pulmonary disease) among adults under 50, threatening their respiratory health and mortality. Researchers found that 4.5% of adults under 50 in the population studied

Diseases

CDC Director Susan Monares Fired Amid Vaccine Policy Controversy

Less than a month after taking office, U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monares was fired on Wednesday, amidst growing controversy over vaccine policies and alleged politicization of public health. Monares' lawyers accused Health and Human Services Secretary Robert Kennedy Jr. of "using

Diseases

Next-Generation CRISPR Gene Editing Tools in Alzheimer's and Parkinson's Disease Treatment

Advances in gene editing technologies, particularly next-generation CRISPR systems, offer promising solutions for the treatment of Alzheimer's and Parkinson's diseases. These technologies, including base editing, prime editing, and engineered Cas variants, have shown improved fidelity and potential for precise gene correction, transcriptional repression or activation, and

Diseases

Chronic Obstructive Pulmonary Disease Market Forecast 2024-2034: Competitive Intelligence & Growth Drivers for Pharma Stakeholders

The chronic obstructive pulmonary disease (COPD) market is expected to experience steady growth in the coming years, driven primarily by increasing diagnosed prevalent cases and the introduction of novel biologics and combination therapies by key COPD companies, including Sanofi, Regeneron Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and Amgen. The report forecasts that the

Diseases

Tocantins State in Brazil Takes Proactive Measures against Foot-and-Mouth Disease and Avian Influenza

The government of Tocantins, through the Agricultural Defense Agency (Adapec) and the State Health Department (SES/TO), has initiated active surveillance actions between August 25th and 29th to prevent the spread of foot-and-mouth disease in cattle and avian influenza on Bananal Island. The efforts aim to ensure the health of

Diseases

CDC Director Susan Monarez Fired After Less Than a Month on the Job

Susan Monarez's tenure as director of the U.S. Centers for Disease Control and Prevention (CDC) was cut short just 28 days into her job, sparking controversy and allegations of politicization of public health. Key Takeaways: * Susan Monarez was fired as director of the CDC on August 27,

Diseases

Agitation in Alzheimer's Disease Market Size to Witness Significant Growth During the Forecast Period

The Alzheimer's disease market, particularly the agitation subset, is expected to experience a substantial increase in market size, primarily driven by the aging population, especially in developed countries where Alzheimer's disease prevalence is higher. Emerging therapies, such as TransCon hGH, HyTropin (GX-H9), Somatrogon, and others, are

Diseases

Alzheimer's Disease Pipeline Insight 2025: Emerging Therapies and Key Companies

DelveInsight's analysis highlights that the Alzheimer's Disease pipeline comprises over 110 key companies actively engaged in developing more than 120 treatment therapies. The report provides comprehensive insights into the clinical development activities of the Alzheimer's Disease therapeutics market, including the therapeutic assessment by product

See all